
GLP-1 weight-loss medications linked to improved cancer survival in certain patients
Fox News
New study shows colon cancer patients taking GLP-1 drugs like Ozempic had 15% mortality vs. 37% for non-users over five years, suggesting significant survival benefits.
Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
They found that the patients were much less likely to die within five years than those who weren’t taking the drugs.
More Related News













